chemical

Nelfinavir mesylate

3766

10 mg (also 50 mg)

182 USD

3766

3766/10

Nelfinavir mesylate

Potent HIV-1 protease inhibitor

Additional Synthetic Protease Inhibitors

Small Molecules

10 mg (also 50 mg)

98%

663.89

?utm_source=distributor&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules

Orally active human immunodeficiency virus protease inhibitor. Potently inhibits HIV-1 protease (Ki = 2 nM) in vitro . Also exhibits anti-MERS-CoV activity in Vero cells in vitro (IC50 = 0.08 M).

3766

Orally active human immunodeficiency virus proteases inhibitors Potent inhibits HIV-1 HIV1 HIV AG1341 AG 1341 Pfizer COVID-19 MERS-CoV middle eastern respiratory virus coronavirus AG 1341 COVID-19 HIV Protease HIV Coronavirus 3766, HIV, human immunodeficiency virus, acquired immunodeficiency syndrome

Potent HIV-1 protease inhibitor

(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2- hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide methanesulfonate

C 32 H 45 N 3 O 4 S.CH 4 O 3 S

C32H45N3O4S.CH4O3S

159989-65-8

175

182 USD

AG 1341

Store at +4°C